Post Thumb

Elon Musk’s Neuralink Gets $27 Million to Build Brain Computers

Neuralink Corp., the startup co-founded by billionaire Elon Musk, has taken steps to sell as much as $100 million in stock to fund the development of technology that connects human brains with computers.

Post Thumb

Elon Musk says he has ‘verbal approval’ to build New York-DC hyperloop

Elon Musk in 90 Seconds New York to DC in half an hour. Elon Musk — the serial entrepreneur who heads Tesla (TSLA), SpaceX and now The Boring Company — says he “just received verbal [government] approval” to build a new underground hyperloop network that can shuttle commuters between the two citie…

Post Thumb

How AI Is Transforming Drug Creation

Pharmaceutical companies hope computers can help them find new medications that are faster, cheaper-and more likely to be effective.

Post Thumb

IBM launches enterprise-ready blockchain service

International Business Machines Corp has launched a service that will allow businesses to build applications on its cloud using blockchain code from the Hyperledger Project, the cross-industry group led by the Linux Foundation.

Post Thumb

Former NASA chief unveils $100 million neural chip maker KnuEdge

It’s not all that easy to call KnuEdge a startup. Created a decade ago by Daniel Goldin, the former head of the National Aeronautics and Space Administration, KnuEdge is only now coming out of stealth mode. It has already raised $100 million in funding to build a “neural chip” that Goldin says will make data centers more efficient in a hyperscale age.

Post Thumb

Cancer patient receives 3D-printed sternum and ribs in world-first surgery

Australian 3D printing company and government-backed Lab 22 3D printed the world’s first sternum and rib cage for a Spanish cancer patient. This remarkable implant was fully customized to replace the damage caused by a chest wall sarcoma.

Post Thumb

New Appoach targets Cancer Stem Cells and uses tens of thousands of animal models | NextBigFuture.com

Stemcentrx, has raised $500 million and is valued at $3 billion, people familiar with its finances say, a nearly unprecedented value for a company with no revenue, facing the usual R and D obstacles, and that almost no one has heard of. Silicon Valley is used to “unicorns,” those private, usually profitless, and fast-growing tech companies worth a billion dollars or more, like Snapchat, Square, and Uber. Now the same phenomenon is spreading to biotech, where investors are throwing money at companies that promise to beat the historically low odds of drug success. The company is unusual because it’s betting on a scientific idea that’s not universally accepted-that cancer is caused not by any cell that goes rogue, but by rare and powerful cancer stem cells. Stemcentrx’s contrarian premise-that stem cells can be bad, not good-has drawn some impressive backers, including Sequoia Capital, Elon Musk, and most notably Founders Fund, the investment firm led by Peter Thiel, the Midas-touch

Post Thumb

Baidu Relying on Deep Learning to Make it Easier to Talk to Your Devices

Baidu says it is building a 100-billion-neuron deep learning system and that it will be complete within six months, powering a fast transition away from text for search requests. With smartphones and the company’s new Baidu Eye technology, the company expects voice and image search to be more used than text.